May 14, 2020 10:56 AM EDT
News Briefing

ADC up­sizes IPO of­fer­ing in search of a $175M-plus haul; No­vo presents en­cour­ag­ing GLP-1 da­ta from obe­si­ty study

John Carroll

Editor & Founder

Natalie Grover

Reporter

→ Swiss biotech ADC Ther­a­peu­tics is up­siz­ing its IPO of­fer­ing by about 3 mil­lion shares. The lat­est up­date in­cludes new plans to sell 10 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

In sur­prise move, FDA's No. 2 Bum­pus to leave agency at end of 2024

Tessera gets up to $50M from the Gates Foun­da­tion; Tvar­di’s re­verse merg­er

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

A service from the Financial Times